Abstract
Emerging evidence suggests the gastrointestinal tract plays an important glucoregulatory role. In this perspective, we first review how the intestine senses ingested nutrients, initiating crucial negative feedback mechanisms through a gut-brain neuronal axis to regulate glycemia, mainly via reduction in hepatic glucose production. We then highlight how intestinal energy sensory mechanisms are responsible for the glucose-lowering effects of bariatric surgery, specifically duodenal-jejunal bypass, and the antidiabetic agents metformin and resveratrol. A better understanding of these pathways lays the groundwork for intestinally targeted drug therapy for the treatment of diabetes.
Original language | English (US) |
---|---|
Pages (from-to) | 367-380 |
Number of pages | 14 |
Journal | Cell Metabolism |
Volume | 22 |
Issue number | 3 |
DOIs | |
State | Published - Sep 1 2015 |
Externally published | Yes |
ASJC Scopus subject areas
- Physiology
- Molecular Biology
- Cell Biology